Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model von Zhang, Yan, Tan, Hui, Daniels, Jacob D., Zandkarimi, Fereshteh, Liu, Hengrui, Brown, Lewis M., Uchida, Koji, O'Connor, Owen A., Stockwell, Brent R.

Volltext

The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management von Marchi, Enrica, O’Connor, Owen A.

Volltext

DeLTA 2.0: A deep learning pipeline for quantifying single-cell spatial and temporal dynamics von O'Connor, Owen M, Alnahhas, Razan N, Lugagne, Jean-Baptiste, Dunlop, Mary J

Volltext

Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma von Hamadani, Mehdi, Radford, John, Carlo-Stella, Carmelo, Caimi, Paolo F., Reid, Erin, O'Connor, Owen A., Feingold, Jay M., Ardeshna, Kirit M., Townsend, William, Solh, Melhem, Heffner, Leonard T., Ungar, David, Wang, Luqiang, Boni, Joseph, Havenith, Karin, Qin, Yajuan, Kahl, Brad S.

Volltext

Brentuximab Vedotin von Deng, Changchun, Pan, Beiqing, O'Connor, Owen A

Volltext

Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study von Falchi, Lorenzo, Ma, Helen, Klein, Sandra, Lue, Jennifer K., Montanari, Francesca, Marchi, Enrica, Deng, Changchun, Kim, Hye A., Rada, Aishling, Jacob, Alice T., Kinahan, Cristina, Francescone, Mark M., Soderquist, Craig R., Park, David C., Bhagat, Govind, Nandakumar, Renu, Menezes, Daniel, Scotto, Luigi, Sokol, Lubomir, Shustov, Andrei R., O'Connor, Owen A.

Volltext

Perspectives on the Mature T-Cell Lymphomas in the Middle East: A Comprehensive Review of the Present Status von Al-Mansour, Mubarak, Aga, Syed Sameer, O'Connor, Owen A

Volltext

Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour act... von Wilson, Wyndham H, Prof, O'Connor, Owen A, Prof, Czuczman, Myron S, Prof, LaCasce, Ann S, MD, Gerecitano, John F, MD, Leonard, John P, Prof, Tulpule, Anil, MD, Dunleavy, Kieron, MD, Xiong, Hao, PhD, Chiu, Yi-Lin, PhD, Cui, Yue, PhD, Busman, Todd, MS, Elmore, Steven W, PhD, Rosenberg, Saul H, PhD, Krivoshik, Andrew P, MD, Enschede, Sari H, MD, Humerickhouse, Rod A, MD

Volltext

Nurturing a diet rich in PTCL von O'Connor, Owen A.

Volltext

Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin von Horwitz, Steven M., Advani, Ranjana H., Bartlett, Nancy L., Jacobsen, Eric D., Sharman, Jeff P., O'Connor, Owen A., Siddiqi, Tanya, Kennedy, Dana A., Oki, Yasuhiro

Volltext

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma von Amengual, Jennifer E., Lichtenstein, Renee, Lue, Jennifer, Sawas, Ahmed, Deng, Changchun, Lichtenstein, Emily, Khan, Karen, Atkins, Laine, Rada, Aishling, Kim, Hye A., Chiuzan, Codruta, Kalac, Matko, Marchi, Enrica, Falchi, Lorenzo, Francescone, Mark A., Schwartz, Lawrence, Cremers, Serge, O'Connor, Owen A.

Volltext

A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the Novel Proteasome Inhibitor Carfilzomib (PR-171) in Patients with Hematologic Malignancies von O'Connor, Owen A., Stewart, A. Keith, Vallone, Marcy, Molineaux, Christopher J., Kunkel, Lori A., Gerecitano, John F., Orlowski, Robert Z.

Volltext

Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study von O'Connor, Owen A., Falchi, Lorenzo, Lue, Jennifer K., Marchi, Enrica, Kinahan, Cristina, Sawas, Ahmed, Deng, Changchun, Montanari, Francesca, Amengual, Jennifer E., Kim, Hye A., Rada, Aishling M., Khan, Karen, Jacob, Alice T., Malanga, Michelle, Francescone, Mark M., Nandakumar, Renu, Soderquist, Craig R., Park, David C., Bhagat, Govind, Cheng, Bin, Risueño, Alberto, Menezes, Daniel, Shustov, Andrei R., Sokol, Lubomir, Scotto, Luigi

Volltext

Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma von Shah, Jatin J, Jakubowiak, Andrzej J, O'Connor, Owen A, Orlowski, Robert Z, Harvey, R Donald, Smith, Mitchell R, Lebovic, Daniel, Diefenbach, Catherine, Kelly, Kevin, Hua, Zhaowei, Berger, Allison J, Mulligan, George, Faessel, Hélène M, Tirrell, Stephen, Dezube, Bruce J, Lonial, Sagar

Volltext

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study von O'Connor, Owen A, Horwitz, Steven, Masszi, Tamás, Van Hoof, Achiel, Brown, Peter, Doorduijn, Jeannette, Hess, Georg, Jurczak, Wojciech, Knoblauch, Poul, Chawla, Shanta, Bhat, Gajanan, Choi, Mi Rim, Walewski, Jan, Savage, Kerry, Foss, Francine, Allen, Lee F, Shustov, Andrei

Volltext

Management of Angioimmunoblastic T-Cell Lymphoma (AITL) and other T Follicular Helper Cell lymphomas (TFH PTCL) von Ma, Helen, O'Connor, Owen A., Marchi, Enrica

Volltext

Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study von O'CONNOR, Owen A, PRO, Barbara, JACOBSEN, Eric, LUIGI ZINZANI, Pier, FURMAN, Richard, GOY, Andre, HAIOUN, Corinne, CRUMP, Michael, ZAIN, Jasmine M, HSI, Eric, BOYD, Adam, HORWITZ, Steven, PINTER-BROWN, Lauren, BARTLETT, Nancy, POPPLEWELL, Leslie, COIFFIER, Bertrand, JO LECHOWICZ, Mary, SAVAGE, Kerry J, SHUSTOV, Andrei R, GISSELBRECHT, Christian

Volltext

Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma von O'Connor, Owen A, Özcan, Muhit, Jacobsen, Eric D, Roncero, Josep M, Trotman, Judith, Demeter, Judit, Masszi, Tamás, Pereira, Juliana, Ramchandren, Radhakrishnan, Beaven, Anne, Caballero, Dolores, Horwitz, Steven M, Lennard, Anne, Turgut, Mehmet, Hamerschlak, Nelson, d'Amore, Francesco A, Foss, Francine, Kim, Won-Seog, Leonard, John P, Zinzani, Pier Luigi, Chiattone, Carlos S, Hsi, Eric D, Trümper, Lorenz, Liu, Hua, Sheldon-Waniga, Emily, Ullmann, Claudio Dansky, Venkatakrishnan, Karthik, Leonard, E Jane, Shustov, Andrei R

Volltext

Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies von Deng, Changchun, Lipstein, Mark R., Scotto, Luigi, Jirau Serrano, Xavier O., Mangone, Michael A., Li, Shirong, Vendome, Jeremie, Hao, Yun, Xu, Xiaoming, Deng, Shi-Xian, Realubit, Ronald B., Tatonetti, Nicholas P., Karan, Charles, Lentzsch, Suzanne, Fruman, David A., Honig, Barry, Landry, Donald W., O'Connor, Owen A.

Volltext

Computed tomography and patient risk:Facts,perceptions and uncertainties von Power, Stephen P, Moloney, Fiachra, Twomey, Maria, James, Karl, O'Connor, Owen J, Maher, Michael M

Volltext